Paper discussed in today's episode:Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More